Home » Topics » Substance use and poisoning, BioWorld Science

Substance use and poisoning, BioWorld Science
RSS

Anticalin shows promise in vitro

March 16, 2004

Positive phase I/II results for NicVAX

March 4, 2004

Cytos' Immunodrug for nicotine addiction enters phase II trial in smokers

Jan. 20, 2004

ICL-670 in beta-thalassemia and associated transfusional iron overload

Dec. 12, 2003

Preliminary phase III results for Vivitrex show reductions in heavy drinking

Dec. 11, 2003

Potential use of SB-277011-A in preventing relapse to cocaine abuse

Nov. 28, 2003

Promising results for ferumoxytol in anemia and chronic kidney disease

Nov. 27, 2003

Britannia and US WorldMeds sign licensing agreement for lofexidine

Nov. 21, 2003

Novel 5-HT and/or dopamine receptor ligands discovered by Sepracor team

Nov. 19, 2003

Antalarmin reduces volitional ethanol consumption in rats

Nov. 18, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Kymera’s IRF5 degrader shows potential in IBD treatment
BioWorld Science
At the recently concluded Digestive Disease Week, researchers from Kymera Therapeutics Inc. presented preclinical efficacy data on KT-579, a selective oral IRF5...